-
1
-
-
78650502245
-
US Renal Data System 2010 Annual Data Report
-
Abstract
-
Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. US Renal Data System 2010 Annual Data Report (Abstract). Am J Kidney Dis 2011;57(1 Suppl. 1):A8
-
(2011)
Am J Kidney Dis
, vol.57
, Issue.1 SUPPL. 1
-
-
Collins, A.J.1
Foley, R.N.2
Herzog, C.3
Chavers, B.4
Gilbertson, D.5
Ishani, A.6
-
2
-
-
33751215833
-
Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002
-
DOI 10.1111/j.1464-5491.2006.01986.x
-
Stewart JH, McCredie MR, Williams SM; ESRD Incidence Study Group. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet Med 2006;23:1364-1369 (Pubitemid 44787802)
-
(2006)
Diabetic Medicine
, vol.23
, Issue.12
, pp. 1364-1369
-
-
Stewart, J.H.1
McCredie, M.R.E.2
Williams, S.M.3
-
3
-
-
0037213037
-
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
-
DOI 10.1046/j.1523-1755.2003.00712.x
-
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-232 (Pubitemid 35463925)
-
(2003)
Kidney International
, vol.63
, Issue.1
, pp. 225-232
-
-
Adler, A.I.1
Stevens, R.J.2
Manley, S.E.3
Bilous, R.W.4
Cull, C.A.5
Holman, R.R.6
-
4
-
-
77957661790
-
How to improve renal outcome in diabetes and hypertension - The importance of early screening for and treatment of microalbuminuria
-
de Zeeuw D, Lambers Heerspink HJ, Gansevoort RT, Bakker SJL. How to improve renal outcome in diabetes and hypertension - the importance of early screening for and treatment of microalbuminuria. Eur Nephr 2009;3:13-15
-
(2009)
Eur Nephr
, vol.3
, pp. 13-15
-
-
De Zeeuw, D.1
Lambers Heerspink, H.J.2
Gansevoort, R.T.3
Bakker, S.J.L.4
-
5
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
-
Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
Lehnert, H.2
Bröchner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
6
-
-
7444221237
-
Preventing microalbuminuria in type 2 diabetes
-
DOI 10.1056/NEJMoa042167
-
Ruggenenti P, Fassi A, Ilieva AP, et al.; Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004;351:1941-1951 (Pubitemid 39447135)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.19
, pp. 1941-1951
-
-
Ruggenenti, P.1
Fassi, A.2
Ilieva, A.P.3
Bruno, S.4
Iliev, I.P.5
Brusegan, V.6
Rubis, N.7
Gherardi, G.8
Arnoldi, F.9
Ganeva, M.10
Ene-Iordache, B.11
Gaspari, F.12
Perna, A.13
Bossi, A.14
Trevisan, R.15
Dodesini, A.R.16
Remuzzi, G.17
-
7
-
-
0031724463
-
Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM
-
DOI 10.2337/diacare.21.11.1932
-
Forsblom CM, Groop PH, Ekstrand A, et al. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998;21:1932-1938 (Pubitemid 28478296)
-
(1998)
Diabetes Care
, vol.21
, Issue.11
, pp. 1932-1938
-
-
Forsblom, C.M.1
Groop, P.-H.2
Ekstrand, A.3
Totterman, K.J.4
Sane, T.5
Saloranta, C.6
Groop, L.7
-
8
-
-
84859836382
-
Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 diabetes: A systematic review
-
Hellemons ME, Kerschbaum J, Bakker SJL, et al. Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 diabetes: A systematic review. Diabet Med 2012;29:567-577
-
(2012)
Diabet Med
, vol.29
, pp. 567-577
-
-
Hellemons, M.E.1
Kerschbaum, J.2
Bakker, S.J.L.3
-
9
-
-
0033779538
-
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population
-
Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000;11:1882-1888
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 1882-1888
-
-
Pinto-Sietsma, S.J.1
Janssen, W.M.2
Hillege, H.L.3
Navis, G.4
De Zeeuw, D.5
De Jong, P.E.6
-
10
-
-
36849078690
-
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
-
DOI 10.1093/eurheartj/ehm465
-
Kempf T, Björklund E, Olofsson S, et al. Growth-differentiation factor-15 improves risk strati fication in ST-segment elevation myocardial infarction. Eur Heart J 2007;28:2858-2865 (Pubitemid 350233034)
-
(2007)
European Heart Journal
, vol.28
, Issue.23
, pp. 2858-2865
-
-
Kempf, T.1
Bjorklund, E.2
Olofsson, S.3
Lindahl, B.4
Allhoff, T.5
Peter, T.6
Tongers, J.7
Wollert, K.C.8
Wallentin, L.9
-
11
-
-
65949104299
-
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
-
Khan SQ, Ng K, Dhillon O, et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 2009;30:1057-1065
-
(2009)
Eur Heart J
, vol.30
, pp. 1057-1065
-
-
Khan, S.Q.1
Ng, K.2
Dhillon, O.3
-
12
-
-
34848820630
-
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
-
DOI 10.1161/CIRCULATIONAHA.107.697714
-
Wollert KC, Kempf T, Lagerqvist B, et al. Growth differentiation factor 15 for risk strati fication and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007;116:1540-1548 (Pubitemid 47511417)
-
(2007)
Circulation
, vol.116
, Issue.14
, pp. 1540-1548
-
-
Wollert, K.C.1
Kempf, T.2
Lagerqvist, B.3
Lindahl, B.4
Olofsson, S.5
Allhoff, T.6
Peter, T.7
Siegbahn, A.8
Venge, P.9
Drexler, H.10
Wallentin, L.11
-
13
-
-
77958161566
-
Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy
-
Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetes Care 2010;33:1567-1572
-
(2010)
Diabetes Care
, vol.33
, pp. 1567-1572
-
-
Lajer, M.1
Jorsal, A.2
Tarnow, L.3
Parving, H.H.4
Rossing, P.5
-
14
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
-
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
-
(1999)
Annals of Internal Medicine
, vol.130
, Issue.6
, pp. 461-470
-
-
Levey, A.S.1
Bosch, J.P.2
Lewis, J.B.3
Greene, T.4
Rogers, N.5
Roth, D.6
-
15
-
-
78649846236
-
Statistical methods for assessment of added usefulness of newbiomarkers
-
Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of newbiomarkers. Clin Chem Lab Med 2010;48:1703-1711
-
(2010)
Clin Chem Lab Med
, vol.48
, pp. 1703-1711
-
-
Pencina, M.J.1
D'Agostino, R.B.2
Vasan, R.S.3
-
16
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
-
discussion 207-212
-
Pencina MJ, D'Agostino RBS Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino Sr., R.B.S.2
D'Agostino Jr., R.B.3
Vasan, R.S.4
-
17
-
-
2342571696
-
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker
-
DOI 10.1093/aje/kwh101
-
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882-890 (Pubitemid 38657490)
-
(2004)
American Journal of Epidemiology
, vol.159
, Issue.9
, pp. 882-890
-
-
Pepe, M.S.1
Janes, H.2
Longton, G.3
Leisenring, W.4
Newcomb, P.5
-
18
-
-
77952522577
-
Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes
-
Heger J, Schiegnitz E, von Waldthausen D, Anwar MM, Piper HM, Euler G. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes. J Cell Physiol 2010;224:120-126
-
(2010)
J Cell Physiol
, vol.224
, pp. 120-126
-
-
Heger, J.1
Schiegnitz, E.2
Von Waldthausen, D.3
Anwar, M.M.4
Piper, H.M.5
Euler, G.6
-
19
-
-
8644230017
-
Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
-
DOI 10.1007/s00441-004-0986-3
-
Schlittenhardt D, Schober A, Strelau J, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004;318:325-333 (Pubitemid 39506502)
-
(2004)
Cell and Tissue Research
, vol.318
, Issue.2
, pp. 325-333
-
-
Schlittenhardt, D.1
Schober, A.2
Strelau, J.3
Bonaterra, G.A.4
Schmiedt, W.5
Unsicker, K.6
Metz, J.7
Kinscherf, R.8
-
20
-
-
33646076196
-
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
-
Xu J, Kimball TR, Lorenz JN, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;98:342-350
-
(2006)
Circ Res
, vol.98
, pp. 342-350
-
-
Xu, J.1
Kimball, T.R.2
Lorenz, J.N.3
-
21
-
-
79955703474
-
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
-
Kempf T, Zarbock A, Widera C, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011;17:581-588
-
(2011)
Nat Med
, vol.17
, pp. 581-588
-
-
Kempf, T.1
Zarbock, A.2
Widera, C.3
-
22
-
-
0024410794
-
Albuminuria reflects widespread vascular damage. The steno hypothesis
-
DOI 10.1007/BF00285287
-
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria re flects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-226 (Pubitemid 19136363)
-
(1989)
Diabetologia
, vol.32
, Issue.4
, pp. 219-226
-
-
Deckert, T.1
Feldt-Rasmussen, B.2
Borch-Johnsen, K.3
Jensen, T.4
Kofoed-Enevoldsen, A.5
-
23
-
-
78249249270
-
Macrophage inhibitory cytokine-1 (MIC-1/GDF15): A new marker of all-cause mortality
-
Wiklund FE, Bennet AM, Magnusson PK, et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 2010;9:1057-1064
-
(2010)
Aging Cell
, vol.9
, pp. 1057-1064
-
-
Wiklund, F.E.1
Bennet, A.M.2
Magnusson, P.K.3
-
24
-
-
0032507776
-
Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia
-
DOI 10.1001/archinte.158.9.998
-
Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998;158:998-1004 (Pubitemid 28213577)
-
(1998)
Archives of Internal Medicine
, vol.158
, Issue.9
, pp. 998-1004
-
-
Ravid, M.1
Brosh, D.2
Ravid-Safran, D.3
Levy, Z.4
Rachmani, R.5
-
25
-
-
77953306111
-
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: The MAGIC study
-
Viazzi F, Leoncini G, Conti N, et al. Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin J Am Soc Nephrol 2010;5:1099-1106
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1099-1106
-
-
Viazzi, F.1
Leoncini, G.2
Conti, N.3
-
26
-
-
78650773021
-
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients
-
Viazzi F, Leoncini G, Conti N, et al. Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients. J Hypertens 2010;28:848-855
-
(2010)
J Hypertens
, vol.28
, pp. 848-855
-
-
Viazzi, F.1
Leoncini, G.2
Conti, N.3
-
27
-
-
0043137112
-
Overestimation of the receiver operating characteristic curve for logistic regression
-
Copas JB, Corbett P. Overestimation of the receiver operating characteristic curve for logistic regression. Biometrika 2002;89:315-333
-
(2002)
Biometrika
, vol.89
, pp. 315-333
-
-
Copas, J.B.1
Corbett, P.2
|